Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00872131 · ClinicalTrials.gov registry record
Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 200
- Enrollment target
NCT00872131 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 200 participants.
The verdict
NCT00872131 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This study will attempt to identify gene and brain activity markers that predict whether people with social anxiety disorder will respond to selective serotonin reuptake inhibitor medications.
Interventions
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2008-03 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00872131
The ClinicalTrials.gov registry entry for NCT00872131 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sertraline is the first listed.
NCT00872131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00872131 about?
NCT00872131 is a clinical study titled "Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder". This study will attempt to identify gene and brain activity markers that predict whether people with social anxiety disorder will respond to selective serotonin reuptake inhibitor medications.
What is the current status of trial NCT00872131?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2008-03. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00872131?
The interventions under investigation include: Sertraline (DRUG).
Who is sponsoring clinical trial NCT00872131?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.